520 related articles for article (PubMed ID: 29925692)
21. Evaluation of engineered AAV capsids for hepatic factor IX gene transfer in murine and canine models.
Markusic DM; Nichols TC; Merricks EP; Palaschak B; Zolotukhin I; Marsic D; Zolotukhin S; Srivastava A; Herzog RW
J Transl Med; 2017 May; 15(1):94. PubMed ID: 28460646
[TBL] [Abstract][Full Text] [Related]
22. Activation of the NF-kappaB pathway by adeno-associated virus (AAV) vectors and its implications in immune response and gene therapy.
Jayandharan GR; Aslanidi G; Martino AT; Jahn SC; Perrin GQ; Herzog RW; Srivastava A
Proc Natl Acad Sci U S A; 2011 Mar; 108(9):3743-8. PubMed ID: 21321191
[TBL] [Abstract][Full Text] [Related]
23. Genomic stability of self-complementary adeno-associated virus 2 during early stages of transduction in mouse muscle in vivo.
Ren C; Kumar S; Shaw DR; Ponnazhagan S
Hum Gene Ther; 2005 Sep; 16(9):1047-57. PubMed ID: 16149903
[TBL] [Abstract][Full Text] [Related]
24. In Utero Transfer of Adeno-Associated Viral Vectors Produces Long-Term Factor IX Levels in a Cynomolgus Macaque Model.
Mattar CNZ; Gil-Farina I; Rosales C; Johana N; Tan YYW; McIntosh J; Kaeppel C; Waddington SN; Biswas A; Choolani M; Schmidt M; Nathwani AC; Chan JKY
Mol Ther; 2017 Aug; 25(8):1843-1853. PubMed ID: 28462816
[TBL] [Abstract][Full Text] [Related]
25. Dexamethasone Transiently Enhances Transgene Expression in the Liver When Administered at Late-Phase Post Long-Term Adeno-Associated Virus Transduction.
Chai Z; Zhang X; Dobbins AL; Samulski RJ; Merricks EP; Nichols TC; Li C
Hum Gene Ther; 2022 Feb; 33(3-4):119-130. PubMed ID: 34617445
[TBL] [Abstract][Full Text] [Related]
26. A new HDV mouse model identifies mitochondrial antiviral signaling protein (MAVS) as a key player in IFN-β induction.
Suárez-Amarán L; Usai C; Di Scala M; Godoy C; Ni Y; Hommel M; Palomo L; Segura V; Olagüe C; Vales A; Ruiz-Ripa A; Buti M; Salido E; Prieto J; Urban S; Rodríguez-Frias F; Aldabe R; González-Aseguinolaza G
J Hepatol; 2017 Oct; 67(4):669-679. PubMed ID: 28527664
[TBL] [Abstract][Full Text] [Related]
27. Toll-like receptor 2-mediated innate immune response in human nonparenchymal liver cells toward adeno-associated viral vectors.
Hösel M; Broxtermann M; Janicki H; Esser K; Arzberger S; Hartmann P; Gillen S; Kleeff J; Stabenow D; Odenthal M; Knolle P; Hallek M; Protzer U; Büning H
Hepatology; 2012 Jan; 55(1):287-97. PubMed ID: 21898480
[TBL] [Abstract][Full Text] [Related]
28. Modulation of tolerance to the transgene product in a nonhuman primate model of AAV-mediated gene transfer to liver.
Mingozzi F; Hasbrouck NC; Basner-Tschakarjan E; Edmonson SA; Hui DJ; Sabatino DE; Zhou S; Wright JF; Jiang H; Pierce GF; Arruda VR; High KA
Blood; 2007 Oct; 110(7):2334-41. PubMed ID: 17609423
[TBL] [Abstract][Full Text] [Related]
29. Stable human FIX expression after 0.9G intrauterine gene transfer of self-complementary adeno-associated viral vector 5 and 8 in macaques.
Mattar CN; Nathwani AC; Waddington SN; Dighe N; Kaeppel C; Nowrouzi A; Mcintosh J; Johana NB; Ogden B; Fisk NM; Davidoff AM; David A; Peebles D; Valentine MB; Appelt JU; von Kalle C; Schmidt M; Biswas A; Choolani M; Chan JK
Mol Ther; 2011 Nov; 19(11):1950-60. PubMed ID: 21629224
[TBL] [Abstract][Full Text] [Related]
30. AAV as an immunogen.
Vandenberghe LH; Wilson JM
Curr Gene Ther; 2007 Oct; 7(5):325-33. PubMed ID: 17979679
[TBL] [Abstract][Full Text] [Related]
31. Application of polyploid adeno-associated virus vectors for transduction enhancement and neutralizing antibody evasion.
Chai Z; Sun J; Rigsbee KM; Wang M; Samulski RJ; Li C
J Control Release; 2017 Sep; 262():348-356. PubMed ID: 28789965
[TBL] [Abstract][Full Text] [Related]
32. Cytotoxic-T-lymphocyte-mediated elimination of target cells transduced with engineered adeno-associated virus type 2 vector in vivo.
Li C; Hirsch M; DiPrimio N; Asokan A; Goudy K; Tisch R; Samulski RJ
J Virol; 2009 Jul; 83(13):6817-24. PubMed ID: 19369348
[TBL] [Abstract][Full Text] [Related]
33. Selection and evaluation of clinically relevant AAV variants in a xenograft liver model.
Lisowski L; Dane AP; Chu K; Zhang Y; Cunningham SC; Wilson EM; Nygaard S; Grompe M; Alexander IE; Kay MA
Nature; 2014 Feb; 506(7488):382-6. PubMed ID: 24390344
[TBL] [Abstract][Full Text] [Related]
34. Capsid antigen presentation flags human hepatocytes for destruction after transduction by adeno-associated viral vectors.
Pien GC; Basner-Tschakarjan E; Hui DJ; Mentlik AN; Finn JD; Hasbrouck NC; Zhou S; Murphy SL; Maus MV; Mingozzi F; Orange JS; High KA
J Clin Invest; 2009 Jun; 119(6):1688-95. PubMed ID: 19436115
[TBL] [Abstract][Full Text] [Related]
35. Recombinant adeno-associated virus-mediated in utero gene transfer gives therapeutic transgene expression in the sheep.
David AL; McIntosh J; Peebles DM; Cook T; Waddington S; Weisz B; Wigley V; Abi-Nader K; Boyd M; Davidoff AM; Nathwani AC
Hum Gene Ther; 2011 Apr; 22(4):419-26. PubMed ID: 20919876
[TBL] [Abstract][Full Text] [Related]
36. Muscle as a target for supplementary factor IX gene transfer.
Hoffman BE; Dobrzynski E; Wang L; Hirao L; Mingozzi F; Cao O; Herzog RW
Hum Gene Ther; 2007 Jul; 18(7):603-13. PubMed ID: 17594244
[TBL] [Abstract][Full Text] [Related]
37. STAU1 binds to IBDV genomic double-stranded RNA and promotes viral replication via attenuation of MDA5-dependent β interferon induction.
Ye C; Yu Z; Xiong Y; Wang Y; Ruan Y; Guo Y; Chen M; Luan S; Zhang E; Liu H
FASEB J; 2019 Jan; 33(1):286-300. PubMed ID: 29979632
[TBL] [Abstract][Full Text] [Related]
38. Role of the vector genome and underlying factor IX mutation in immune responses to AAV gene therapy for hemophilia B.
Rogers GL; Martino AT; Zolotukhin I; Ertl HC; Herzog RW
J Transl Med; 2014 Jan; 12():25. PubMed ID: 24460861
[TBL] [Abstract][Full Text] [Related]
39. Improved induction of immune tolerance to factor IX by hepatic AAV-8 gene transfer.
Cooper M; Nayak S; Hoffman BE; Terhorst C; Cao O; Herzog RW
Hum Gene Ther; 2009 Jul; 20(7):767-76. PubMed ID: 19309290
[TBL] [Abstract][Full Text] [Related]
40. Preclinical in vivo evaluation of pseudotyped adeno-associated virus vectors for liver gene therapy.
Grimm D; Zhou S; Nakai H; Thomas CE; Storm TA; Fuess S; Matsushita T; Allen J; Surosky R; Lochrie M; Meuse L; McClelland A; Colosi P; Kay MA
Blood; 2003 Oct; 102(7):2412-9. PubMed ID: 12791653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
